The following table provides an overview of the latest patents of Eisai R&d Management Co., Ltd. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3581183Nov 29, 2023Tumor-Treating Pharmaceutical Composition1
EP3263106Oct 25, 2023Method For Suppressing Bitterness Of Quinoline Derivative8
EP3524595Aug 10, 2022High-Purity Quinoline Derivative And Method For Manufacturing Same9
EP3265122May 4, 2022Combination Of A Pd-1 Antagonist And Eribulin For Treating Cancer4
EP3338779Jun 30, 2021Tumor Therapeutic Agent1